NASDAQ · Medical - Devices

PRCT (PRCT) Stock

$19.34 +5.80% NASDAQ: PRCT Healthcare

Valuation

MetricValue
Price$19.34
Market Cap$1.10B
P/E Ratio-32.52
P/B Ratio4.70
P/S Ratio4.62
EPS (TTM)$-1.72
52-Week High$62.17
52-Week Low$16.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-27.81%
ROA-13.54%
ROCE-28.42%
Gross Margin62.98%
Operating Margin-33.86%
Net Margin-31.82%
Debt/Equity0.15
Current Ratio6.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$34.0M$75.0M$136.0M$224.0M$308.0M
Operating Profit$-54.0M$-81.0M$-109.0M$-97.0M$-104.0M
Net Profit$-60.0M$-87.0M$-106.0M$-91.0M$-96.0M
EPS$-1.37$-1.96$-2.24$-1.75$-1.72
Op Margin-157.1%-107.6%-80.2%-43.0%-33.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$337.0M$309.0M$405.0M$534.0M$508.0M
Total Liabilities$70.0M$112.0M$124.0M$132.0M$142.0M
Cash$304.0M$223.0M$257.0M$334.0M$287.0M
Borrowings$54.0M$77.0M$79.0M$80.0M$52.0M

Latest News

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors GlobeNewswire · Jul 15, 2026 PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 GlobeNewswire · Jul 14, 2026 Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 MT Newswires · Jul 6, 2026 Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential Insider Monkey · Jun 30, 2026 Establishment Labs® Appoints Taylor Harris to Board of Directors Business Wire · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-57.0M$-80.0M$-108.0M$-99.0M$-49.0M
Investing Cash Flow$-1.0M$-5.0M$-50.0M$-9.0M$-19.0M
Financing Cash Flow$5.0M$2.0M$6.0M$16.0M$0
Net Cash Flow$204.0M$-79.0M$35.0M$77.0M$-47.0M
Free Cash Flow$-58.0M$-83.0M$-133.0M$-104.0M$-58.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.91
EV / EBITDA-14.31
FCF Yield-4.93%
Quick Ratio5.51
Interest Coverage-26.00
Return 1Y-70.78%
Return 3Y-51.39%
Return 5Y—

Ownership

Insiders Held3.17%
Institutions Held102.45%
Institutions Float Held105.80%
Institutional HolderSharesReport Date
Blackrock Inc.4,362,0022026-03-31
T. Rowe Price Investment Management, Inc.3,273,7942026-03-31
BNP Paribas Asset Management Holding S.A.3,089,3782026-03-31
Vanguard Portfolio Management LLC2,421,3622026-03-31
Vanguard Capital Management LLC2,399,0672026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AORT $27.12 +2.07% 108.24 $1.32B 0.00%
BGMBGM Group Ltd. $0.30 -1.10% -1.82 $59.61M 0.00%
CLOV $4.76 +2.15% 48.35 $2.47B 0.00%
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
GRDN $43.83 +11.05% 45.92 $2.78B 0.00%

About PRCT

PRCT is led by CEO Larry L. Wood, employs 756 people, headquartered in US, publicly traded since 2021.

PRCT stock trades at $19.34 with a market capitalization of $1.10B. The stock is valued at a price-to-earnings (P/E) ratio of -32.52, price-to-book of 4.70, price-to-sales of 4.62. Over the past 52 weeks the stock has ranged between $16.69 and $62.17, and currently trades 68.9% below its 52-week high.

On profitability, PRCT generates a return on equity (ROE) of -27.81%, return on capital employed of -28.42%, an operating margin of -33.86%, a net profit margin of -31.82%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides